Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in the fibrillin-1 gene with a prevalence of approximately 1110,000.~~~ However, molecular diagnosis is not generally available, mutation detection is imperfect, and not all fibrillin-l mutations are associated with Marfan syndrome. For these reasons, Marfan syndrome is diagnosed clinically using a set of diagnostic criteria based on evaluation of family history, molecular data, and six organ systems.
The diagnostic criteria for Marfan syndrome wete recently revised from the previous "Berlin" criteria3 into a stricter "Ghent" formulation.? Both criteria evaluate family history and skeletal, ocular, cardiovascular, pulmonary, skin/ integumentary, and central nervous system manifestations. Under the Berlin criteria, patients are diagnosed based on involvement of the skeletal system and two other systems with at least one major manifestation (ectopia lentis, aortic dilation] dissection, or dural ectasia). Patients with an affected firstdegree relative are required to have involvement of at least two other systems with one major manifestation preferred but not required. The revised Ghent formulation requires involvement ofthree systems with two major diagnostic manifestations. Additionally, the Ghent criteria provide for major skeletal manifestations and consider affected first-degree relatives or molecular data as major diagnostic criteria ( Table 1) .
The revision of these nosologies stemmed from concern that the older Berlin criteria did not provide for molecular data and evidence that they falsely diagnosed unaffected relatives.'..'.5 However, some investigators have argued that the new criteria are too stringent and may exclude the diagnosis of Marfan syndrome from many affected patients.* Similarly, the utiliv of screening for dural ectasia (a finding with greater impact under the revised criteria) is unknown.
The diagnosis of Marfan syndrome has important medical, personal, and reproductive consequences for patients and their families. We report a comparison ofthe Berlin and Ghent criteria and the influence of screening for dural ectasia in the diagnosis of Marfan syndrome among patients seen at the National lnstitutes of Health.
We reviewed clinical and radiographic data on 73 consecutive patients evaluated for possible Marfan syndrome at the National Institutes of Health. All patients were enrolled in a molecular etiology and natural history study approved by the National lnstitutes of Health National Human Genome Research Institute Instirutional Review Board with written informed consent (NIH protocol 97-HG-0089).
All patients were examined by at least one geneticist experienced in diagnosing Marfan syndrome and related connective tissue disorders (HPL, CAF). Aortic root dilation was defined by the criteria of Roman et al. as seen on transthoracic echocardiography.' Dural ectasia was defined by the criteria of Ahn and colleagues based on magnetic resonance imaging (MRI) of the lumbosacral spine.* Cornea plana was defined by keratom~e n e % r~ Medicine In the absence o f a n affected I" degree relative, involvement of the skeleton and two other systems with at least one major manifestation.
In the presence of an i%fected I" degree relative, involvement of at least two systems. etry measurements < 42 diopters in adult patients (since no clear standards exist for this determination in children, we did not use this classification in pediatric patients). All patients were classified as affected or unaffected based on the published standards of the Berlin and Ghent criteria.
Ghent diagnost~c criteria

RESULTS
Seventy-three patients ranged in age from 1 month to 62 years at the time of evaluation. Sex ratio showed a nonsignificant male predominance (M:F = 48:25, P > 0.05). Thirty one patients (42%) had an affected first degree relative, and we clinically confirmed this diagnosis in 22 cases. All patients were examined by a geneticist, and all had echocardiograms, cardiac MRI imaging, and/or known aortic root dilation or dissection. Sixty-four (88%) had complete ophthalmologic examination by ophthalmologists familiar with ocular manifestations of Marfan syndrome or known ectopia lentis. Thirty-six (48%) had a lumbosacral MRI to evaluate dural ectasia. Complete eye examination was generally not obtained in young children. Similarly, lumbosacral MRI results were generally unavailable for claustrophobic patients, young children, and adults in whom spinal instrumentation prohibited imaging or scoliosis compromised image interpretation.
The clinical summary of patients evaluated for Marfan syndrome appears in Table 2 . Nine of 48 patients (19%) who met the Berlin diagnostic criteria did not meet the Ghent standard. This proportion did not change when only patients with complete clinical and MRI data were analyzed (seven of 32 of these patients (22%) met Berlin but not Ghent diagnostic criteria). A clinical summary of the nine patients excluded under the Ghent criteria is presented in Table 3 . All had either ( 1) no major diagnostic manifestations and an affected first degree relative or (2) aortic root dilation but no other major diagnostic manifestations.
Dural ectasia constituted the second major diagnostic manifestation (without which the diagnosis of Marfan syndrome would not be supported) for 9 of 39 patients (23%) diagnosed under the Ghent criteria. The clinical characteristics of these patients are presented in Table 4 . Presence or absence of dural ectasia had no effect on diagnoses made under the Berlin criteria. Additionally, dural ectasia was not found in any of the patients who were diagnosed under the Berlin nosology but excluded by the Ghent criteria (absent in seven, not evaluated in two).
DISCUSSION
Accurate diagnosis of Marfan syndrome has important research, medical, and personal implications for patients, but some degree of uncertainty is inherent in any diagnosis dependent on clinical criteria. For example, determination of some skeletal features is necessarily subjective, and clear guidelines do not exist for interpretation of eye findings such as keratometry measurements in children or the finding of visible zonules in the absence of ectopia lentis. Nonetheless, in the absence of a highly sensitive and specific "gold standard" for diagnosis, determination of affected status in Marfan syndrome necessarily requires the use of clinical criteria such as the Berlin or Ghent diagnostic nosologies.
These results indicate that approximately 20% of patients diagnosed with Marfan syndrome under the Berlin criteria fail to meet the Ghent diagnostic standard. Of the nine patients whose diagnoses changed under the Ghent criteria, all had either (1) no major diagnostic manifestations and an affected relative or (2) aortic root dilation but no other major diagnostic manifestations. Those in the first group all had mild systemic features often seen in the general population (for example, skin striae or mild skeletal features). Although we lack the molecular data or long-term follow-up to absolutely exclude the inheritance of a fibrillin-1 mutation in these patients, they are clinically unaffected with Marfan syndrome. In the second group, all had aortic root dilation but no other major diagnostic features of Marfan syndrome. Three of these four patients displayed subtle systemic manifestations clinically compatible with a non-Marfan fibrillinopathy such as MASS phenotype' or familial aortic aneurysm'" rather than true Marfan syndrome. The remaining patient (Table 3 , patient number eight), a 22 year old male with a history of aortic root dilation, spontaneous pneumothorax, and minor manifestations of the skel- No case of incomplete penetrance has ever been demonstrated for patients carrying fibrillin-1 mutations associated with Marfan syndrome.I1 However, patients with the same mutation can show a wide degree of phenotypic variability. This has been exemplified in the large pedigrees reported by Dietz and colleagues and the report of monozygotic twins with sharp differences in clinical severity of musculoskeletal and cardiovascular features of the ~y n d r o m e . '~, '~ Continued clinical and molecular studies are necessary to determine the genetic risk and natural history of patients who meet the Berlin but not Ghent diagnostic criteria. The importance of screening for dural ectasia in the diagnosis of Marfan syndrome has not been established. As a major diagnostic manifestation, the condition has greater significance under the revised Ghent criteria. Dural ectasia is most closely associated with Marfan syndrome and is a sensitive clinical manifestation of the d i s~r d e r . l *~~ However, dural ectasia is also found in patients with Ehlers-Danlos syndrome and neurofibromatosis,16 and the prevalence of dural ectasia in non-Marfan fibrillinopathies or other overlap connective tissue disorders has not been studied. Presence and severity of Assessment of dural ectasia is often not performed during evaluation for Marfan syndrome because of cost, difficulties in interpreting images, and perceived lack of clinical benefit. The condition is best evaluated by lumbosacral MRI, although computed tomography (CT)8.1h and plain radiographs can also be used for diagnosis (N.U. Ahn, unpublished data, 2000) . Most authors report a prevalence of approximately 65%,17 although some investigators report figures as high as 92%.15 Severity seems to increase with age, supporting the hypothesis that a weakened dural sac expands from the cumulative effect of increased intrathecal pressure at the base of the spine from upright posture. Formal standards for the evaluation of MRI and CT images for dural ectasia have recently been published and should allow standardization of the diagnosis of dural ectasia.8 Suitable MRI images of the lumbosacral spine were obtained on only half of our patients. Many were not obtained or were uninterpretable because of young age, claustrophobia, or spinal instrumentation or scoliosis. In those evaluated, dural ectasia was the second most predictive major diagnostic finding under both the Berlin and Ghent criteria. Dural ectasia constituted the second major diagnostic manifestation for one fourth of patients diagnosed under the Ghent criteria (without which the diagnosis of Marfan syndrome would not be supported, see Table 4 for clinical descriptions). Dural ectasia is also associated with headache, back pain, and nerve compression.^-m These findings support the clinical and diagnostic value of screening patients with suspected Marfan syndrome for dural ectasia.
In summary, approximately 20% of patients diagnosed with Marfan syndrome under the Berlin criteria failed to meet the Ghent diagnostic standard. Determination of dural ectasia is valuable in the evaluation of Marfan syndrome and established the diagnosis under the Ghent criteria in one fourth ofpatients. The Ghent criteria appropriately exclude some patients, but further long-term follow-up or reliable molecular diagnostic techniques are necessary to establish the relative sensitivity and specificity of the Berlin and Ghent criteria as diagnostic tools.
